ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
7.18
-0.05 (-0.69%)
At close: Jun 3, 2026, 4:00 PM EDT
7.12
-0.06 (-0.84%)
After-hours: Jun 3, 2026, 4:07 PM EDT
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $7.52 billion as of June 3, 2026. Its market cap has increased by 200.00% in one year.
Market Cap
7.52B
Enterprise Value
8.16B
1-Year Change
200.00%
Ranking
Category
Stock Price
$7.18
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $7.52B, a decrease of -49.27%. That is a compound annual growth rate of -12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 7.57B | 288.28% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 9.34B |
| Krystal Biotech | 8.79B |
| Halozyme Therapeutics | 8.08B |
| Bio-Techne | 7.95B |
| Corcept Therapeutics | 7.56B |
| Nuvalent | 7.35B |
| Vaxcyte | 7.06B |
| Immunovant | 6.75B |